Newstral
Article
The Hindu on 2021-08-24 13:58
Gennova’s mRNA-based COVID-19 vaccine gets approval for Phase 2/3 clinical trials
Related news
- Moderna enters clinical trials for its mRNA-based flu vaccineengadget
- BSanofi and Translate Bio Begin Clinical Trials of mRNA-Based Covid-19 Vaccinebarrons.com
- Covid: Zydus initiates phase I, II clinical trialsThe Times of India
- Moderna begins early-stage trials of mRNA-based HIV vaccineengadget
- TChina: Phase III clinical trials for anti-goiter drug begintumblerridgenews.com
- Covid: Pune-based co plans human trials in OctThe Times of India
- Moderna’s personalised mRNA cancer vaccine shows promise for next phase of trialsSouth China Morning Post
- COVISHIELD completes enrolment of Phase-3 clinical trials under partnership of ICMR, Serum Institute of IndiaThe Hindu
- Covaxin Phase 2&3 trials to resume in US after USFDA lifts clinical holdThe Times of India
- Male contraceptive pill reports successful results from Phase 1 clinical trialsnewatlas.com
- Glenmark begins Phase-3 clinical trials on antiviral drug Favipiravir for COVID-19 patients in IndiaThe Hindu
- The Emerging Benefit Of Personalized, Phase 1 Clinical Trials In OncologyForbes
- U.S. FDA puts on hold Covaxin’s phase 2/3 clinical trialsThe Hindu
- Mysuru-based JSS Academy to carry out clinical trials for Novavax COVID-19 vaccineThe Hindu
- UK-based Beckley Psytech raises £14 million to advance drug discovery to clinical trialstech.eu
- COVID-19: DCGI nod to SII for phase 2 and 3 human clinical trials of Oxford vaccine candidateThe Hindu
- Archigen Biotech seeks FDA Approval for Rituximab Phase I Clinical Trialsjdsupra.com
- Moderna Announces New England Journal of Medicine Publication of Pivotal Phase 3 Clinical Safety and Efficacy Data For MRNA-1345, The Company’s Investigational Respiratory Syncytial Virus (RSV) Vaccinesacbee.com
- Coronavirus live updates | Over 100 experts from friendly nations trained for clinical trials of Indian vaccineThe Hindu
- Zydus Cadila's DNA-based vaccine for those 12 and above gets emergency use approvalThe Hindu